ABBVIE FDA Approval NDA 018279

NDA 018279

ABBVIE

FDA Drug Application

Application #018279

Documents

Letter2012-02-17
Label2013-11-26
Label2014-07-03
Letter2004-12-30
Letter2018-05-03
Label2018-05-08

Application Sponsors

NDA 018279ABBVIE

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET, EXTENDED RELEASE;ORAL10MEQ1K-TABPOTASSIUM CHLORIDE
002TABLET, EXTENDED RELEASE;ORAL8MEQ1K-TABPOTASSIUM CHLORIDE
003TABLET, EXTENDED RELEASE;ORAL20MEQ1K-TABPOTASSIUM CHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1980-06-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1981-02-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1981-01-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1981-04-29STANDARD
LABELING; LabelingSUPPL5AP1982-11-10
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1982-07-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1984-08-01STANDARD
LABELING; LabelingSUPPL8AP1984-08-13
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1985-03-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1986-01-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1986-10-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1986-06-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1987-06-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1988-08-01STANDARD
LABELING; LabelingSUPPL16AP1988-08-01
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1989-11-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1990-03-26STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1993-01-27STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1996-11-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL22AP1997-10-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1998-04-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL24AP2002-10-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL25AP2002-12-24STANDARD
LABELING; LabelingSUPPL27AP2004-12-14STANDARD
LABELING; LabelingSUPPL29AP2012-02-15UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL30AP2014-09-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL31AP2013-08-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL32AP2014-06-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL33AP2013-11-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL34AP2014-06-26STANDARD
LABELING; LabelingSUPPL37AP2018-04-30STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL6Null0
SUPPL7Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL14Null0
SUPPL15Null0
SUPPL17Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL24Null0
SUPPL25Null0
SUPPL29Null15
SUPPL30Null0
SUPPL31Null0
SUPPL32Null0
SUPPL33Null0
SUPPL34Null0
SUPPL37Null7

TE Codes

001PrescriptionAB3
002PrescriptionBC
003PrescriptionAB3

CDER Filings

ABBVIE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 18279
            [companyName] => ABBVIE
            [docInserts] => ["",""]
            [products] => [{"drugName":"K-TAB","activeIngredients":"POTASSIUM CHLORIDE","strength":"10MEQ","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"K-TAB","activeIngredients":"POTASSIUM CHLORIDE","strength":"8MEQ","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"K-TAB","activeIngredients":"POTASSIUM CHLORIDE","strength":"20MEQ","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"04\/30\/2018","submission":"SUPPL-37","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/018279Orig1s037lbl.pdf\"}]","notes":""},{"actionDate":"06\/26\/2014","submission":"SUPPL-34","supplementCategories":"Manufacturing (CMC)","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/018279s034lbl.pdf\"}]","notes":"This supplement type does not usually require new labeling."},{"actionDate":"11\/25\/2013","submission":"SUPPL-33","supplementCategories":"Manufacturing (CMC)","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/018279s033lbl.pdf\"}]","notes":"This supplement type does not usually require new labeling."}]
            [originalApprovals] => [{"actionDate":"K-TAB","submission":"POTASSIUM CHLORIDE","actionType":"10MEQ","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"K-TAB","submission":"POTASSIUM CHLORIDE","actionType":"8MEQ","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"K-TAB","submission":"POTASSIUM CHLORIDE","actionType":"20MEQ","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2018-04-30
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.